February 27, 2018 / 2:32 PM / 6 months ago

BRIEF-Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta

Feb 27 (Reuters) - Amgen Inc:

* AMGEN RECEIVES POSITIVE CHMP OPINION FOR DELIVERY SYSTEM OF NEULASTA® (PEGFILGRASTIM)

* AMGEN INC - CHMP OF EMA ISSUED A POSITIVE OPINION RECOMMENDING A LABEL VARIATION FOR NEULASTA TO INCLUDE NEULASTA ONPRO KIT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below